REVIEW article

Front. Behav. Neurosci., 07 June 2023

Sec. Pathological Conditions

Volume 17 - 2023 | https://doi.org/10.3389/fnbeh.2023.1147784

CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models

  • 1. Department of Electronics Engineering, Satya Wacana Christian University, Salatiga, Indonesia

  • 2. Department of Experimental Therapy, University Hospital Erlangen and Preclinical Experimental Animal Center, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany

  • 3. Noldus Information Technology BV, Wageningen, Netherlands

  • 4. Myers Neuro-Behavioral Core Facility, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel

  • 5. Donders Center for Neuroscience, Radboud University, Nijmegen, Netherlands

  • 6. School of Behavioral Sciences, Netanya Academic College, Netanya, Israel

Article metrics

View details

42

Citations

15,8k

Views

3,7k

Downloads

Abstract

Automated gait assessment tests are used in studies of disorders characterized by gait impairment. CatWalk XT is one of the first commercially available automated systems for analyzing the gait of rodents and is currently the most used system in peer-reviewed publications. This automated gait analysis system can generate a large number of gait parameters. However, this creates a new challenge in selecting relevant parameters that describe the changes within a particular disease model. Here, for the first time, we performed a multi-disorder review on published CatWalk XT data. We identify commonly reported CatWalk XT gait parameters derived from 91 peer-reviewed experimental studies in mice, covering six disorders of the central nervous system (CNS) and peripheral nervous system (PNS). The disorders modeled in mice were traumatic brain injury (TBI), stroke, sciatic nerve injury (SNI), spinal cord injury (SCI), Parkinson’s disease (PD), and ataxia. Our review consisted of parameter selection, clustering, categorization, statistical evaluation, and data visualization. It suggests that certain gait parameters serve as potential indicators of gait dysfunction across multiple disease models, while others are specific to particular models. The findings also suggest that the more site-specific the injury is, the fewer parameters are reported to characterize its gait abnormalities. This study strives to present a clearly organized picture of gait parameters used in each one of the different mouse models, potentially helping novel CatWalk XT users to apply this information to similar or related mouse models they are working on.

The circular bar plots depict that publications of a system injury reported more CatWalk gait parameters in comparison to publications of a site-specific injury.

1. Introduction

Adaptation of gait dynamics is a prominent symptom of many neurological and movement disorders and injuries, such as sciatic nerve injury (Bozkurt et al., 2008), spinal cord injury (Hendriks et al., 2006), traumatic brain injury (Neumann et al., 2009), multiple sclerosis (Bernardes et al., 2017), Parkinson’s disease, Huntington disease, and stroke (Vandeputte et al., 2010). Over the last few decades, various methods have been developed for the assessment of rodent gait dynamics. Among the earliest methods for evaluating gait parameters are static footprint analysis (i.e., ink-based foot analysis), open-field observations, the Basso, Beattie, and Bresnahan (BBB) score (Basso et al., 1995), and Basso Mouse Scale (BMS) score (Basso et al., 2006).

Currently, many researchers use automated behavioral tests to observe and quantify the gait performance of rodents. Automated gait analysis methods provide objective, reliable, and sensitive measurements of locomotor and gait abnormalities compared to earlier methods (Garrick et al., 2021). Moreover, the automation of gait analysis has enabled the monitoring of a new set of time-based parameters that were previously impossible to observe, such as swing duration and inter-limb coordination (Kappos et al., 2017). Finally, automation has facilitated the assessment of mouse gait and made it possible for more users to perform gait assessments in mice, resulting in an increased number of published studies and increased variety of tested models (Figure 1).

FIGURE 1

CatWalk XT, developed by Noldus Information Technology, was among the first commercially available automated system for gait analysis. CatWalk XT is a camera-based system that quantifies gait performance in rodents. The use of CatWalk XT in various rodent models of human neurological diseases has steadily increased since its initial development by Hamers et al. (2001, 2006). CatWalk XT has been instrumental in increasing the popularity of gait analysis as a valuable behavioral endpoint, making it one of the most used automated gait analysis systems worldwide (Figure 1).

As an automated gait analysis system, CatWalk XT has the advantage of generating a large number of gait parameters easily and reliably in freely moving mice, in contrast to treadmill-based systems where animals are forced to walk. Moreover, unlike treadmill systems, CatWalk XT makes use of complete internal reflection of green light within a glass walkway. The green light escapes the glass walkway when the paw of an animal that traverses the walkway touches the glass, and it is reflected by the tissue of the paw toward a 100 frame per second color camera positioned below the glass walkway. Due to this principle, only actual footfalls are detected, and the beginning and end of each footfall can be determined with 10 ms accuracy (i.e., 1 frame). This highly precise spatial and temporal detection of footfalls allows the CatWalk XT software to generate over 200 static and dynamic gait parameters for rats and mice (Timotius et al., 2018a, 2019).

The CatWalk XT system can identify impairments in multiple gait and motor function parameters, including Stride Length, Stand Time, Swing Time, Duty Cycle, Regularity Index, Print Area, and Swing Speed (see Table 1 for additional parameters). Moreover, the system is able to identify subtle changes in paw use and movement patterns that may have gone undetected with non-automated assays of freely moving animals. The comprehensive set of gait parameters provided by CatWalk XT allows researchers to gain an in-depth understanding of how different forms of central nervous system (CNS; e.g., ataxia, Parkinson’s disease, traumatic brain injury, stroke, and spinal cord injury) and peripheral nervous system (PNS; e.g., sciatic nerve injury) injuries affect motor and gait function. A recent paper demonstrated the effectiveness of the CatWalk XT system in an experimental stroke model by revealing significant alterations in 21% of the analyzed CatWalk XT gait parameters (Chen et al., 2020). One study of a Parkinson’s disease (PD) mouse model evaluated 62 CatWalk XT gait parameters and indicated 15 to be more closely related to the animal’s genotype (Radlicka et al., 2023). Another study detected differences in 84 CatWalk XT gait parameters between a specific PD mouse model and its wild-type littermates (Timotius et al., 2018a, 2019). In a study of an ataxia mouse model (Perez et al., 2021), mice with ataxia experienced a progressive deterioration in their motor coordination, as evidenced by their decreased use of three paws (as opposed to one, two, or four paws) while crossing the CatWalk XT walkway. Additionally, mice displayed slower speed and cadence during each run across the platform, possibly indicative of muscle weakness. In the sciatic nerve injury (SNI) model, it was reported that the coordination-related CatWalk XT gait parameters were highly correlated with neuropathic pain severity and response to analgesic treatment (Xu et al., 2019). In an experimental thoracic injury model, Zheng et al. (2023) assessed paw intensity and size; however, as these are parameters affected by weight, they developed a ratio score (hind-limb/fore-limb ratio of pixel intensity of paw prints and paw print size). They discovered that such a ratio was highly effective in evaluating locomotor function impairment and recovery (Zheng et al., 2023).

TABLE 1

No.CatWalk XT parametersGroup
1Run duration/other statistics durationTemporal
2Run average speed/other statistics average speed/body speed meanTemporal
3Run maximum variation/other statistics maximum variation/body speed variation meanTemporal
4Stand (s) meanTemporal
5Stand (s) SD*Temporal
6Stand index meanTemporal
7Max contact at (%) meanTemporal
8The mean of max intensity at (%)Temporal
9Swing (s) meanTemporal
10Swing (s) SD*Temporal
11Swing speed (cm/s) meanTemporal
12Swing speed (cm/s) SD*Temporal
13Step cycle (s) meanTemporal
14Duty cycle (%) meanTemporal
15Single stance (s) meanTemporal
16Initial dual stance (s) meanTemporal
17Terminal dual stance (s) meanTemporal
18Other statistics number of stepsTemporal
19Other statistics cadenceTemporal
20Right hip/right knee/left hip/left knee/nose/abdomen/tail/genitalia (%)Temporal
21Phase dispersion parameters/phase lagTemporal
22Coupling parametersTemporal
23Stride length (cm) mean or normalized stride lengthSpatial
24BOS front paws mean (cm)Spatial
25BOS hind paws mean (cm)Spatial
26Print positionsSpatial
27Sway parametersSpatial
28Support zero (%)Support
29Support single (%)Support
30Support diagonal (%)Support
31Support girdle (%)Support
32Support lateral (%)Support
33Support three (%)Support
34Support four (%)Support
35Step sequence number of patternsCoordination
36Step sequence CA (%)*Coordination
37Step sequence CB (%)*Coordination
38Step sequence AA (%)*Coordination
39Step sequence AB (%)*Coordination
40Step sequence RA (%)*Coordination
41Step sequence RB (%)*Coordination
42Step sequence regularity index (%)Coordination
43Max contact area (cm2) meanPrint
44Print length (cm) meanPrint
45Print width (cm) meanPrint
46Print area (cm2) meanPrint
47Toe spread (cm) meanPrint
48Paw angle body axis (°) meanPrint
49Paw angle movement vector (°) meanPrint
50Intermediate toe spreadPrint
51Sciatic functional index (SFI)Print
52Fibular functional index (FFI)Print
53Intensity ratio and asymmetryOthers
54Difference scoreOthers
55Combined CatWalk index (CCI)Others
56Stand ratio/stride length ratio/step cycle ratio/swing speed ratio/print length ratio/print width ratioOthers
57Phase dispersion asymmetry/coupling asymmetryOthers
58Print area RH/LH* ratio or duty cycle RH/LH* ratioOthers

The CatWalk XT parameters and grouping of parameters used in Figure 2.

*RF, right fore; LF, left fore; RH, right hind; LH, left hind; SD, standard deviation; CA, cruciate sequence (RF-LF-RH-LH); CB, cruciate sequence (LF-RF-LH-RH); AA, alternate sequence (RF-RH-LF-LH); AB, alternate sequence (LF-RH-RF-LH); RA, rotary sequence (RF-LF-LH-RH); RB, rotary sequence (LF-RF-RH-LH).

One limitation of automated systems is that extracting a wide array of parameters can pose a challenge, namely selecting the most appropriate data and/or parameters that define the changes within the disease model being examined. One method for parameter selection is to rely on previous publications. However, this approach may not always be viable since not all studies report the same parameters, and replication may not be possible (Timotius et al., 2018a, 2019). Nevertheless, by accessing data from multiple studies and identifying key significant parameters replicated for each animal model, we can provide a review of these parameters that (1) may indicate differences between focal and non-focal insult models (e.g., SNI vs. stroke); (2) may serve as main alerting parameters of general gait dysfunction, as these would be affected irrespective of the mouse model; or (3) may help differentiate between mouse models, enabling to use gait analysis for differential diagnosis between various biological and/or neurological insults.

2. Materials and methods

We collected and examined a total of 91 published pre-clinical studies using the CatWalk XT analysis system related to traumatic brain injury (TBI), stroke, sciatic nerve injury (SNI), spinal cord injury (SCI), Parkinson’s disease (PD), and ataxia. The electronic search was performed using several search engines (i.e., PubMed and Google Scholar) and ended in March 2022. The keywords used in the search process were CatWalk, rodents, mouse, mice, and the diseases of interest for our study. The majority of the studies (86%) were published between 2017 and 2022 (Baiguera et al., 2012; Bernardes et al., 2017; Caballero-Garrido et al., 2017; Carboni et al., 2017; Chen et al., 2017, 2019, 2020; Cline et al., 2017; Fujimaki et al., 2017; Hayashi et al., 2017; Hsieh et al., 2017; Matyas et al., 2017; Mountney et al., 2017; Ni et al., 2017; Pöttker et al., 2017; Rocca et al., 2017; Roth et al., 2017; Schönfeld et al., 2017; Crowley et al., 2018, 2019; Du et al., 2018a,b; Frahm et al., 2018; Fröhlich et al., 2018; Liu et al., 2018, 2019; Lu et al., 2018; Mozafari et al., 2018; Noristani et al., 2018; Okuwa et al., 2018; Sowa et al., 2018; Su et al., 2018; Timotius et al., 2018b,2021; Truong et al., 2018; Zhu et al., 2018; Cross et al., 2019; Guy et al., 2019; Kolosowska et al., 2019; Leite et al., 2019; Ma et al., 2019; Minakaki et al., 2019; Minarelli et al., 2019; Miterko et al., 2019; Pacheco et al., 2019; Thau-Zuchman et al., 2019; Bengoa-Vergniory et al., 2020; Campos-Pires et al., 2020; Chung et al., 2020; Goldshmit et al., 2020; Goncalves et al., 2020; Heinzel et al., 2020a; Henry et al., 2020; Lin et al., 2020, 2022; Murphy et al., 2020; Namdar et al., 2020; Neckel et al., 2020; Pinkowski et al., 2020; Ritzel et al., 2020, 2021; Schweizer et al., 2020; Walter et al., 2020; Weber et al., 2020; Wilke et al., 2020; Bärmann et al., 2021; Deng et al., 2021; Gries et al., 2021; Huang et al., 2021, 2022; Knorr et al., 2021; Mallah et al., 2021; Niewiadomska-Cimicka et al., 2021; Perez et al., 2021; Wang et al., 2021; Zheng et al., 2021; Chai et al., 2022; Haas et al., 2022; Wertheim et al., 2022). The rest of the studies were published in 2016 or before (Baiguera et al., 2012; Hetze et al., 2012; Wang et al., 2012; Balkaya et al., 2013; Streijger et al., 2013; Casadei et al., 2014; Forgione et al., 2014; Qin et al., 2014; Rotermund et al., 2014; Tsika et al., 2014; Hayakawa et al., 2015; Saal et al., 2015; Kyriakou et al., 2016; Tatenhorst et al., 2016; Vidal et al., 2017). The details of the publications are summarized in Table 2. An important element in comparing studies in research synthesis or systematic review is determining publication bias and data heterogeneity within and across studies. To minimize the potential for bias, we implemented several steps to ensure the rigor and quality of the included articles. These steps included retrieving papers with no conflicts of interest, examining the methods and results and ensuring that sufficient numbers of animals were used per group (n ≥ 10, with exceptions of two publications in PD and one publication in SCI, where n ≤ 10, which were included due to the limited number of publications using mouse models), and sourcing all papers from indexed journals that employ a rigorous review process (see more information on journal name and impact factor in Supplementary material). From the collected publications, we examined which gait parameters were reported. For each gait parameter used, we evaluated whether any significant difference was reported in the publications compared to healthy controls or baseline levels. The numbers of publications in percent reported for all gait parameters are presented in a circular stack bar plot (Figure 2). In the event that, due to certain circumstances, one independent study reported both a significant increase and a significant decrease in a given gait parameter, the circular stack bar plot displays the differences that were more prominent or prevalent. The gait parameters were arranged in the circular stack bar plot according to their main category. Currently, there is no universal gait parameter grouping; rather, the grouping depends on the experimental model used and the research question of interest. In this study, inspired by Caballero-Garrido et al. (2017), we have grouped the gait parameters into six categories: temporal, spatial, support, coordination, print, and others. The grouping of these gait parameters is listed in Table 1.

TABLE 2

Related diseaseExperimental modelsNumber of publications
Traumatic brain injury (TBI)(a) Controlled cortical impact
(b) Repeated closed-head injury
(c) Single closed-head injury
(d) Blast exposure injury
20
Stroke(a) Photothrombotic
(b) Ischemic
(c) Chronic
(d) Middle cerebral artery occlusion (MCAO)
(e) Distal MCAO
(f) Subarachnoid hemorrhage
11
Sciatic nerve injury (SNI)(a) Sciatic nerve axonotmesis
(b) Sciatic nerve constriction injury
(c) Sciatic nerve neurotmesis
(d) Sciatic nerve fibrosis
20
Spinal cord injury (SCI)(a) Thoracic contusion
(b) Thoracic hemisection
(c) Thoracic laminectomy
(d) Cervical hemicontusion
(e) Cervical decompression
(f) Cervical compression
(g) TrkB.T1 astrocytic knockout
12
Parkinson’s disease (PD)(a) 6-hydroxydopamine (6-OHDA) neurotoxin model
(b) Synthetic preformed fibrils (PFF) injections
(c) Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin model
(d) R1441C LRRK2 transgenic mouse model
(e) Alpha-synuclein transgenic mouse model
15
Ataxia(a) Ataxia type 3
(b) Ataxia type 4
(c) Ataxia type 7
(d) Ataxia type 17
13

Experimental models and the number of publications that utilized CatWalk XT as a gait analysis system.

FIGURE 2

CatWalk XT parameters not reported in any publication were not included in the circular stack bar plot. The paw statistic parameters of each paw were clustered together. Print position parameters were clustered together, as were the different coupling parameters. Phase dispersion and phase lag parameters were also clustered together. In addition, parameters that were measured by different methods but had similar meanings were clustered

together: Run Duration and Other Statistics Duration; Run Average Speed, Other Statistics Average Speed, and Body Speed Mean; Run Maximum Variation, Other Statistics Maximum Variation, and Body Speed Variation Mean. Likewise, gait parameters related to non-paw contact to the walkway (the contact of hip, knee, nose, abdomen, tail, and genitalia) were clustered together. New parameters derived from the standard CatWalk XT parameters were also included. Parameters depicting asymmetric effects between the right and left limbs were clustered together. Normalized or scaled parameters (e.g., normalized by body length, size, or weight) were clustered with the equivalent non-normalized parameters. Gait parameters related to paw pixel intensity are highly influenced by the experimental settings, and therefore, they were not included in the circular stack bar plot. As a result, the total number of gait parameters presented in the circular stack bar plot is 58.

From these 58 gait parameters and all collected publications, the total number of CatWalk XT gait parameters reported for each disease is depicted in a horizontal bar plot. Depending on the direction of change, these parameters were classified as significant increase, significant decrease, and no significant difference. In the event that one publication reported a significant increase in a given gait parameter, whereas another publication reported the opposite, the visualization in the horizontal bar plot was determined based on the number of publications reporting the increase vs. decrease. Such discrepancy between studies may be due to the different experimental settings and designs and the use of animals of different strains, ages, and sex.

We used spider plots to visualize the differences between disease-related experimental models (Figure 3). The spider plots visualize whether each gait parameter increases, decreases, lacks significant change, or was not reported. The decision if a gait parameter was considered to increase or decrease is based on the data presented in Figure 2 (circular bar plot). Here, we show the circular plot of two parameter groups, i.e., spatial and coordination. The number of disease-related experiment models was limited to enable an understandable visualization of spider plots for novice users. Additionally, we chose several parameters based on the previous circular bar plots and visualized them in a spider plot. The review process is depicted in Figure 4.

FIGURE 3

FIGURE 4

3. Results

3.1. Reported gait parameters for each disease model

The reported CatWalk XT gait parameters were visualized using circular stack bar plots, as shown in Figure 2. The corresponding gait parameter names and groupings of parameters are given in Table 1. Following are the parameters that are reported in all six diseases.

The total number of reported gait parameters for each disease is visualized in Figure 5. Studies of TBI and stroke reported considerably more gait parameters than any other disease model, a total of 42 gait parameters. Out of these, stroke studies reported the highest number of gait parameters showing a significant difference between injured and control groups, i.e., 32. By contrast, studies on SCI reported fewer gait parameters, i.e., 13.

FIGURE 5

3.2. Comparing gait parameters between disease models

Figures 3A, B show the spider plots of the spatial and coordination parameters for four different disease models. These plots inform us if a gait parameter is mostly reported as having a significant increase, significant decrease, no significant difference, or was not reported. Overall, the results show that stride length significantly decreases in PD, SCI, and stroke but not in SNI. The base of support (BOS) of the front paws increases in PD but decreases in stroke and is not reported in SNI and SCI. BOS of hind paws and print position increase in SNI, PD, and SCI but decreases in stroke. The sway parameter is a new secondary spatial parameter developed for PD (Timotius et al., 2018b); therefore, it is not reported in the other models. In the spider plot for coordination parameters, the regularity index (RI) decreases in all diseases, and RI was the only coordination parameter reported in SNI and SCI studies.

Based on the circular bar plots in Figure 2, several gait parameters show a consistent direction of change within a disease model, and these parameters are reported by at least 25% of the publications in the respective disease. For example, all PD publications that reported a significant change in swing speed reported a decreasing trend. These gait parameters include run speed (always decreased in stroke), stand time (always increased in SCI and PD), swing speed (always decreased in stroke, SCI, and PD), stride length (always decreased in stroke, SCI, and ataxia), regularity index (always decreased in SCI), maximum contact area (always decreased in stroke). We generated a separate spider plot for these parameters for stroke, SCI, PD, and ataxia (Figure 3C).

4. Discussion

Automated gait analysis systems, such as CatWalk XT or DigiGait™, measure hundreds of different parameters. Therefore, one of the main challenges is identifying the relevant parameters for a specific disease model. The present work was designed to facilitate an efficient literature-based selection of CatWalk XT parameters for future studies in several mouse models. To do so, this study performed a comprehensive review of reported gait abnormalities for six PNS and CNS diseases: TBI, stroke, SNI, SCI, PD, and ataxia.

Our findings suggest that certain parameters may be more appropriate than others for specific models, while others may not be as useful. For example, the average duty cycle in TBI showed limited evidence of significant change, while the average swing time in TBI showed mixed results. The average BOS of the hind paws also showed limited promise for TBI studies, with the majority of reports indicating no significant change. In contrast, the average BOS of the hind paws in ataxia and average swing time in SNI had more consistent evidence of significant change (increase), suggesting their potential usefulness in those models. Similarly, the increasing average BOS of the hind paws in SCI and decreasing average toe spread in SNI had more consistent evidence of significant change, indicating that these parameters may be more relevant for those models. The change in hind paw BOS or the absence of change in the different models (see Figure 3A) may reflect different compensatory mechanisms to restore balance, as can be seen in different models such as ataxia (Kyriakou et al., 2016) and stroke (Zampogna et al., 2020). Additionally, there were more reports of significant change (decrease or increase) in the average BOS of the front paws in stroke than no significant change, while for the same parameter in TBI and PD, the evidence was mixed.

Our review also suggests that certain gait parameters may serve as potential indicators of gait dysfunction across multiple disease models, while others may be specific to particular models. For instance, changes in phase dispersion / phase lag (which describes the temporal relationship between placement of two paws within a step cycle) and the mean of max intensity at (%, relative to stand time) were consistently reported as significant in TBI and stroke models, implying that they could potentially serve as main alerting parameters of gait dysfunction in these models. In contrast, the parameter “intermediate toe spread” was distinctive to the SNI model. However, in some cases it was decreased (Knorr et al., 2021) and in others increased (Okuwa et al., 2018), maybe due to differences in the SNI models. This phenotype highlights the potential use of toe spread as a core parameter for assessing SNI-related gait dysfunction or testing novel therapies. A further finding of our review is that the less site-specific the injury at the origin of the model (e.g., TBI, stroke), the more parameters will be significantly changed by the injury, possibly due to the extensive and variable nature of the effect on brain of the insult in these models, compared to the restricted effect that is seen when a specific nerve is damaged, as in SNI. In other words, the greater the cell loss and the less site-specific the damage, the more severe the effect on the gait.

Another interesting finding is the considerable variation in the direction of gait alteration between animal models of the same disease, a variability that can be observed even when measuring the same gait parameter. One example is print area in SCI animal models, where some publications report a significant increase but others a significant decrease or no change at all. However, an increase or decrease in a single parameter may not necessarily be indicative of gait impairment or recovery (Kyriakou et al., 2016). Instead, it may be due to factors such as the disorder model (e.g., in some TBI or stroke models, the injury may vary from animal to animal depending on the method used for injury), genotype and sex of the animals used, and various experimental factors affecting the standardization of gait recordings (Wahlsten et al., 2003; O’Leary et al., 2013; Kafkafi et al., 2017).

It should be noted that while the primary focus of this work has been gait analysis in pre-clinical mouse models of human diseases, extension to rat models is theoretically plausible. For example, comparable effects on stand time and print area following peripheral nerve injury have been previously reported in both mice and rats (Heinzel et al., 2020b). In addition, a significant decrease in swing speed, duty cycle, and paw print intensity have been observed in both mouse and rat stroke models (Encarnacion et al., 2011; Hetze et al., 2012). Moreover, recent evidence suggests that it is also possible to extend gait analysis to non-motor specific neurodegenerative diseases that are primarily characterized by cognitive deficits, like Alzheimer’s disease (Koivisto et al., 2019; Castillo-Mariqueo et al., 2021; Castillo-Mariqueo and Giménez-Llort, 2022). Thus, it is very likely that, in the future, objective measurement of gait abnormalities could aid in predicting disease onset and progression and improving quality of life also in non-motor-specific diseases.

5. Conclusion and a proposal/Future directions

When investigating data from CatWalk XT, results that align with the literature are easier to understand and interpret. Novel findings that have not been previously reported may represent either a novel discovery or a false positive and, as such, should be further investigated. Our work sorted the existing information from the literature for that exact purpose. Nevertheless, we acknowledge that our method might be limited in its generalizability as it is based solely on reviewing published papers. More concretely, published data carries an inherent bias since it often ignores unreported or omitted information (i.e., non-significant results). Further, the comprehensive phenotyping and understanding of different mouse models of CNS and PNS damage require expertise in numerous disease areas and collaboration between experts. It is hoped that the findings of this study, derived from a comprehensive review of CatWalk XT findings, will promote the standardization of parameter selection and guide new users in selecting parameters. Another important potential bias, which was not discussed in our paper but has significant effects in gait studies, is the details of gait recording protocols, and more importantly the report of these details in publication. Part of our limitations in this paper in providing additional information and guidance is missing information in most papers on the details of used protocols; the full information (room lighting intensity; recording parameters; number of trials per animal; reinforcer used, to name but a few) will greatly help to promote standardization between CatWalk XT users and will encourage users of other systems to report their results with similar high standards. The current literature-based parameter selection should serve as an initial step in exploring further the measured gait parameters. Our next step is to conduct an in-depth meta-analysis of raw data obtained with CatWalk XT from different laboratories that are experts in the investigated models discussed here.

Statements

Author contributions

LB, RR, and IT: conceptualization, methodology, and data analysis. LB, RR, IT, and BR-H: investigation. IT and BR-H: data collection. IT: software and data visualization. IT, RR, BR-H, LN, SH, and LB: writing—review and editing. LB, LN, and SH: supervision. All authors contributed to the article and approved the submitted version.

Funding

This study was provided by financial support for Health Holland to promote public-private partnerships [TKI-LSH EMCLSH21017 (RR)].

Conflict of interest

LN and RR were working for Noldus Information Technology BV, the company that develops and commercializes CatWalk XT. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnbeh.2023.1147784/full#supplementary-material

References

  • 1

    BaigueraC.AlghisiM.PinnaA.BellucciA.De LucaM. A.FrauL.et al (2012). Late-onset Parkinsonism in NFjB/c-Rel-deficient mice.Brain13517501765. 10.1093/brain/aws193

  • 2

    BalkayaM.KröberJ.GertzK.PeruzzaroS.EndresM. (2013). Characterization of long-term functional outcome in a murine model of mild brain ischemia.J. Neurosci. Methods213179187. 10.1016/j.jneumeth.2012.12.021

  • 3

    BärmannJ.WalterH. L.PikhovychA.EndepolsH.FinkG. R.RuegerM. A.et al (2021). An analysis of the CatWalk XT and a composite score to assess neurofunctional deficits after photothrombosis in mice.Neurosci. Lett.751:135811. 10.1016/j.neulet.2021.135811

  • 4

    BassoD. M.BeattieM. S.BresnahanJ. C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats.J. Neurotrauma12121. 10.1089/neu.1995.12.1

  • 5

    BassoD. M.FisherL. C.AndersonA. J.JakemanL. B.MctigueD. M.PopovichP. G. (2006). Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.J. Neurotrauma23635659. 10.1089/neu.2006.23.635

  • 6

    Bengoa-VergnioryN.FaggianiE.Ramos-GonzalezP.KirkizE.Connor-RobsonN.BrownL. V.et al (2020). CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease.Nat. Commun.11:4885. 10.1038/s41467-020-18689-x

  • 7

    BernardesD.LeiteA.OliveiraR. (2017). Comprehensive CatWalk gait analysis in a chronic model of multiple sclerosis subjected to treadmill exercise training.BMC Neurol.17:160. 10.1186/s12883-017-0941-z

  • 8

    BozkurtA.DeumensR.ScheffelJ.O’DeyD. M.WeisJ.JoostenE. A.et al (2008). CatWalk gait analysis in assessment of functional recovery after sciatic nerve injury.J. Neurosci. Methods1739198. 10.1016/j.jneumeth.2008.05.020

  • 9

    Caballero-GarridoE.Pena-PhilippidesJ. C.GalochkinaZ.ErhardtE.RoitbakT. (2017). Characterization of long-term gait deficits in mouse dMCAO, using the CatWalk system.Behav. Brain Res.331282296. 10.1016/j.bbr.2017.05.042

  • 10

    Campos-PiresR.OnggraditoH.UjvariE.KarimiS.ValeoF.AldhounJ.et al (2020). Xenon treatment after severe traumatic brain injury improves locomotor outcome, reduces acute neuronal loss and enhances early beneficial neuroinflammation: A randomized, blinded, controlled animal study.Crit. Care24:667. 10.1186/s13054-020-03373-9

  • 11

    CarboniE.TatenhorstL.TöngesL.BarskiE.DambeckV.BährM.et al (2017). Deferiprone rescues behavioral deficits induced by mild iron exposure in a mouse model of alpha-synuclein aggregation.Neuromol. Med.19309321. 10.1007/s12017-017-8447-9

  • 12

    CasadeiN.PöhlerA.-M.Tomás-ZapicoC.Torres-PerazaJ.SchwedhelmI.WitzA.et al (2014). Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.Hum. Mol. Genet.23767781. 10.1093/hmg/ddt467

  • 13

    Castillo-MariqueoL.Giménez-LlortL. (2022). Clasping, ledge-score coordination and early gait impairments as primary behavioural markers of functional impairment in Alzheimer’s disease.Behav. Brain Res.435:114054. 10.1016/j.bbr.2022.114054

  • 14

    Castillo-MariqueoL.Pérez-GarcíaM. J.Giménez-LlortL. (2021). Modeling functional limitations, gait impairments, and muscle pathology in alzheimer’s disease: Studies in the 3xtg-ad mice.Biomedicines9:1365. 10.3390/biomedicines9101365

  • 15

    ChaiY.ZhaoH.YangS.GaoX.CaoZ.LuJ.et al (2022). Structural alignment guides oriented migration and differentiation of endogenous neural stem cells for neurogenesis in brain injury treatment.Biomaterials280:121310. 10.1016/j.biomaterials.2021.121310

  • 16

    ChenC.-M.ChenW.-L.HungC.-T.LinT.-H.LeeM.-C.ChenI.-C. (2019). Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models.Aging119861007. 10.18632/aging.101804

  • 17

    ChenH.DuJ.ZhangY.BarnesK.JiaX. (2017). Establishing a reliable gait evaluation method for rodent studies.J. Neurosci. Methods28392100. 10.1016/j.jneumeth.2017.03.017

  • 18

    ChenM.LyuH.LiT.SuX. W.LeungC. K.XiongM. Z. Q.et al (2020). Study of the association between gait variability and gene expressions in a mouse model of transient focal ischemic stroke.Int. J. Neurosci.1305263. 10.1080/00207454.2019.1663188

  • 19

    ChungY.-H.LinC.-W.HuangH.-Y.ChenS.-L.HuangH.-J.SunY.-C. (2020). Targeting inflammation, PHA-767491 shows a broad spectrum in protein aggregation diseases.J. Mol. Neurosci.7011401152. 10.1007/s12031-020-01521-y

  • 20

    ClineM. M.YumulJ. C.HysaL.MurraD.GarwinG. G.CookD. G.et al (2017). Novel application of a radial water tread maze can distinguish cognitive deficits in mice with traumatic brain injury.Brain Res.1657140147. 10.1016/j.brainres.2016.11.027

  • 21

    CrossD. J.MeabonJ. S.ClineM. M.RichardsT. L.StumpA. J.CrossC. G. (2019). Paclitaxel reduces brain injury from repeated head trauma in mice.J. Alzheimers Dis.67859874. 10.3233/JAD-180871

  • 22

    CrowleyS. T.FukushimaY.UchidaS.KataokaK.ItakaK. (2019). Enhancement of motor function recovery after spinal cord injury in mice by delivery of brain-derived neurotrophic factor mRNA.Mol. Ther. Nucleic Acids.17465476. 10.1016/j.omtn.2019.06.016

  • 23

    CrowleyS. T.KataokaK.ItakaK. (2018). Combined catwalk index: An improved method to measure mouse motor function using the automated gait analysis system.BMC Res. Notes11:263. 10.1186/s13104-018-3374-x

  • 24

    DengJ.LiM.MengF.LiuZ.WangS.ZhangY.et al (2021). 3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice.Cell Death Dis.12:1096. 10.1038/s41419-021-04398-w

  • 25

    DuJ.ChenH.ZhouK.JiaX. (2018a). Quantitative multimodal evaluation of passaging human neural crest stem cells for peripheral nerve regeneration.Stem Cell Rev. Rep.1492100. 10.1007/s12015-017-9758-9

  • 26

    DuJ.ZhenG.ChenH.ZhangS.QingL.YangX.et al (2018b). Optimal electrical stimulation boosts stem cell therapy in nerve regeneration.Biomaterials181347359. 10.1016/j.biomaterials.2018.07.015

  • 27

    EncarnacionA.HorieN.Keren-GillH.BlissT. M.SteinbergG. K.ShamlooM. (2011). Long-term behavioral assessment of function in an experimental model for ischemic stroke.J. Neurosci. Methods196247257. 10.1016/j.jneumeth.2011.01.010

  • 28

    ForgioneN.KaradimasS. K.FoltzW. D.SatkunendrarajahK.LipA.FehlingsM. G. (2014). Bilateral contusion-compression model of incomplete traumatic cervical spinal cord injury.J. Neurotrauma3117761788. 10.1089/neu.2014.3388

  • 29

    FrahmS.MelisV.HorsleyD.RickardJ. E.RiedelG.FaddaP.et al (2018). Alpha-synuclein transgenic mice, h-alpha-synL62, display alpha-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson’s disease.Behav. Brain Res.339153168. 10.1016/j.bbr.2017.11.025

  • 30

    FröhlichH.ClaesK.De WolfC.Van DammeX.MichelA. (2018). A machine learning approach to automated gait analysis for the Noldus Catwalk system.IEEE Trans. Biomed. Eng.6511331139. 10.1109/TBME.2017.2701204

  • 31

    FujimakiH.UchidaK.InoueG.MiyagiM.NemotoN.SakuT.et al (2017). Oriented collagen tubes combined with basic fibroblast growth factor promote peripheral nerve regeneration in a 15 mm sciatic nerve defect rat model.J. Biomed. Mater. Res.A105814. 10.1002/jbm.a.35866

  • 32

    GarrickJ. M.CostaL. G.ColeT. B.MarsillachJ. (2021). Evaluating gait and locomotion in rodents with the CatWalk.Curr. Protoc.1:e220. 10.1002/CPZ1.220

  • 33

    GoldshmitY.BanyasE.BensN.YakovchukA.RubanA. (2020). Blood glutamate scavengers and exercises as an effective neuroprotective treatment in mice with spinal cord injury.J. Neurosurg. Spine33692704. 10.3171/2020.4.SPINE20302

  • 34

    GoncalvesD. F.GuzmanM. S.GrosR.MassensiniA. R.BarthaR.PradoV. F.et al (2020). Striatal Acetylcholine Helps to Preserve Functional Outcomes in a Mouse Model of Stroke.ASN Neuro12:1759091420961612. 10.1177/1759091420961612

  • 35

    GriesM.ChristmannA.SchulteS.WeylandM.RommelS.MartinM.et al (2021). Parkinson mice show functional and molecular changes in the gut long before motoric disease onset.Mol. Neurodegener.161634. 10.1186/s13024-021-00439-2

  • 36

    GuyR.GrynspanF.Ben-ZurT.PanskiA.LamdanR.DanonU.et al (2019). Human muscle progenitor cells overexpressing neurotrophic factors improve neuronal regeneration in a sciatic nerve injury mouse model.Front. Neurosci.13:151. 10.3389/fnins.2019.00151

  • 37

    HaasE.IncebacakR. D.HentrichT.HuridouC.SchmidtT.CasadeiN.et al (2022). A novel SCA3 knock-in mouse model mimics the human SCA3 disease phenotype including neuropathological, behavioral, and transcriptional abnormalities especially in oligodendrocytes.Mol. Neurobiol.59495522. 10.1007/s12035-021-02610-8

  • 38

    HamersF. P. T.KoopmansG. C.JoostenE. A. J. (2006). CatWalk-assisted gait analysis in the assessment of spinal cord injury.J. Neurotrauma23537548. 10.1089/neu.2006.23.537

  • 39

    HamersF. P. T.LankhorstA. J.van LaarT. J.VeldhuisW. B.GispenW. H. (2001). Automated quantitative gait analysis during overground locomotion in the rat: Its application to spinal cord contusion and transection injuries.J. Neurotrauma18187201. 10.1089/08977150150502613

  • 40

    HayakawaK.UchidaS.OgataT.TanakaS.KataokaK.ItakaK. (2015). Intrathecal injection of a therapeutic gene-containing polyplex to treat spinal cord injury.J. Controll. Release19719. 10.1016/j.jconrel.2014.10.027

  • 41

    HayashiT.OnozatoT.WanajoI.HayashiM.TakedaH.FujimoriY. (2017). Longitudinal analysis of motor symptoms and histopathology in woozy mice, a model of cerebellar ataxia.Neuroreport28779787. 10.1097/WNR.0000000000000816

  • 42

    HeinzelJ.LängleG.OberhauserV.HausnerT.KolbenschlagJ.PrahmC.et al (2020a). Use of the CatWalk gait analysis system to assess functional recovery in rodent models of peripheral nerve injury – a systematic review.J. Neurosci. Methods345:108889. 10.1016/j.jneumeth.2020.108889

  • 43

    HeinzelJ.SwiadekN.AshmweM.RührnößlA.OberhauserV. (2020b). Automated gait analysis to assess functional recovery in rodents with peripheral nerve or spinal cord contusion injury.J. Vis. Exp.164122. 10.3791/61852

  • 44

    HendriksW. T. J.EggersR.RuitenbergM. J.BlitsB.HamersF. P. T.VerhaagenJ.et al (2006). Profound differences in spontaneous long-term functional recovery after defined spinal tract lesions in the rat.J. Neurotrauma231835. 10.1089/neu.2006.23.18

  • 45

    HenryR. J.MeadowsV. E.StoicaB. A.FadenA. I.LoaneD. J. (2020). Longitudinal assessment of sensorimotor function after controlled cortical impact in mice: Comparison of beamwalk, rotarod, and automated gait analysis tests.J. Neurotrauma3727092717. 10.1089/neu.2020.7139

  • 46

    HetzeS.RömerC.TeufelhartC.MeiselA.EngelO. (2012). Gait analysis as a method for assessing neurological outcome in a mouse model of stroke.J. Neurosci. Methods206714. 10.1016/j.jneumeth.2012.02.001

  • 47

    HsiehC.-H.RauC.-S.KuoP.-J.LiuS.-H.WuC.-J.LuT.-H.et al (2017). Knockout of toll-like receptor impairs nerve regeneration after a crush injury.Oncotarget88074180756. 10.18632/oncotarget.20206

  • 48

    HuangS.ChenY.JiaY.YangT.SuW.ZhuZ.et al (2022). Delayed inhibition of ERK and p38 attenuates neuropathic pain without affecting motor function recovery after peripheral nerve injury.Neuropharmacology202:108835. 10.1016/j.neuropharm.2021.108835

  • 49

    HuangZ.-H.FengA.-Y.LiuJ.ZhouL.ZhouB.YuP. (2021). Inhibitor of DNA binding 2 accelerates nerve regeneration after sciatic nerve injury in mice.Neural Regener. Res.16:2542. 10.4103/1673-5374.313054

  • 50

    KafkafiN.GolaniI.JaljuliI.MorganH.SarigT.WürbelH.et al (2017). Addressing reproducibility in single-laboratory phenotyping experiments.Nat. Methods14462464. 10.1038/nmeth.4259

  • 51

    KapposE. A.SieberP. K.EngelsP. E.MarioloA. V.D’ArpaS.SchaeferD. J.et al (2017). Validity and reliability of the CatWalk system as a static and dynamic gait analysis tool for the assessment of functional nerve recovery in small animal models.Brain Behav.7:e00723. 10.1002/brb3.723

  • 52

    KnorrS.RauschenbergerL.LangT.VolkmannJ.IpC. W. (2021). Multifactorial assessment of motor behavior in rats after unilateral sciatic nerve crush injury.J. Vis. Exp.173120. 10.3791/62606

  • 53

    KoivistoH.YtebrouckE.CarmansS.NaderiR.MiettinenP. O.RoucourtB.et al (2019). Progressive age-dependent motor impairment in human tau P301S overexpressing mice.Behav. Brain Res.376:112158. 10.1016/j.bbr.2019.112158

  • 54

    KolosowskaN.KeutersM. H.WojciechowskiS.Keksa-GoldsteineV.LaineM.MalmT.et al (2019). Peripheral administration of IL-13 induces anti-inflammatory microglial/macrophage responses and provides neuroprotection in ischemic stroke.Neurotherapeutics1613041319. 10.1007/s13311-019-00761-0

  • 55

    KyriakouE. I.van der KieftJ. G.de HeerR. C.SpinkA.NguyenH. P.HombergJ. R.et al (2016). Automated quantitative analysis to assess motor function in different rat models of impaired coordination and ataxia.J. Neurosci. Methods268171181. 10.1016/j.jneumeth.2015.12.001

  • 56

    LeiteA. P. S.PintoC. G.TibúrcioF. C.SartoriA. A.de Castro RodriguesA.BarravieraB.et al (2019). Heterologous fibrin sealant potentiates axonal regeneration after peripheral nerve injury with reduction in the number of suture points.Injury50834847. 10.1016/j.injury.2019.03.027

  • 57

    LinC.-W.FanC.-H.ChangY.-C.Hsieh-LiH. M. (2020). ERK activation precedes Purkinje cell loss in mice with Spinocerebellar ataxia type 17.Neurosci. Lett.738:135337. 10.1016/j.neulet.2020.135337

  • 58

    LinY.-S.ChengW.-L.ChangJ.-C.LinT.-T.ChaoY.-C.LiuC.-S. (2022). IGF-1 as a potential therapy for spinocerebellar ataxia type 3.Biomedicines10:505. 10.3390/biomedicines10020505

  • 59

    LiuL.TianD.LiuC.YuK.BaiJ. (2019). Metformin enhances functional recovery of peripheral nerve in rats with sciatic nerve crush injury.Med. Sci. Monit.251006710076. 10.12659/MSM.918277

  • 60

    LiuZ.-K.NgC.-F.ShiuH.-T.WongH.-L.ChinW.-C.ZhangJ.-F.et al (2018). Neuroprotective effect of Da Chuanxiong formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury.J. Ethnopharmacol.2171122. 10.1016/j.jep.2018.02.004

  • 61

    LuL.BaiX.CaoY.LuoH.YangX.KangL.et al (2018). Growth differentiation factor 11 promotes neurovascular recovery after stroke in mice.Front. Cell. Neurosci.12:205. 10.3389/fncel.2018.00205

  • 62

    MaH.LamP. K.TongC. S. W.LoK. K. Y.WongG. K. C.PoonW. S. (2019). The neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury.Cell Transplant.28874884. 10.1177/0963689719855624

  • 63

    MallahK.CouchC.AlshareefM.BoruckiD.YangX.AlawiehA.et al (2021). Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury.Acta Neuropathol. Commun.9:72. 10.1186/s40478-021-01179-6

  • 64

    MatyasJ. J.O’DriscollC. M.YuL.Coll-MiroM.DaughertyS.RennC. L.et al (2017). Truncated TrkB.T1-mediated astrocyte dysfunction contributes to impaired motor function and neuropathic pain after spinal cord injury.J. Neurosci.3739563971. 10.1523/JNEUROSCI.3353-16.2017

  • 65

    MinakakiG.CannevaF.ChevessierF.BodeF.MengesS.TimotiusI. K.et al (2019). Treadmill exercise intervention improves gait and postural control in alpha-synuclein mouse models without inducing cerebral autophagy.Behav. Brain Res.363199215. 10.1016/j.bbr.2018.11.035

  • 66

    MinarelliJ.DavisE. L.DickersonA.MooreW. C.MejiaJ. A.GugalaZ.et al (2019). Characterization of neuromas in peripheral nerves and their effects on heterotopic bone formation.Mol. Pain15:174480691983819. 10.1177/1744806919838191

  • 67

    MiterkoL. N.WhiteJ. J.LinT.BrownA. M.O’DonovanK. J.SillitoeR. V. (2019). Persistent motor dysfunction despite homeostatic rescue of cerebellar morphogenesis in the Car8 waddles mutant mouse.Neural Dev.14:6. 10.1186/s13064-019-0130-4

  • 68

    MountneyA.BouttéA. M.CartagenaC. M.FlerlageW. F.JohnsonW. D.RhoC.et al (2017). Functional and molecular correlates after single and repeated rat closed-head concussion: Indices of vulnerability after brain Injury.J. Neurotrauma3427682789. 10.1089/neu.2016.4679

  • 69

    MozafariR.KyrylenkoS.CastroM. V.FerreiraR. S.BarravieraB.OliveiraA. L. R. (2018). Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair.J. Venomous Anim. Toxins Incl. Trop. Dis.24:11. 10.1186/s40409-018-0147-x

  • 70

    MurphyE. K.IaconoD.PanH.GrimesJ. B.ParksS.RaiciulescuS.et al (2020). Explosive-driven double-blast exposure: Molecular, histopathological, and behavioral consequences.Sci. Rep.10:17446. 10.1038/s41598-020-74296-2

  • 71

    NamdarI.FeldmanR.GlazerS.MeningherI.ShlobinN. A.RubovitchV.et al (2020). Motor effects of minimal traumatic brain injury in mice.J. Mol. Neurosci.70365377. 10.1007/s12031-019-01422-9

  • 72

    NeckelN. D.DaiH.BurnsM. P. (2020). A novel multi-dimensional analysis of rodent gait reveals the compensation strategies used during spontaneous recovery from spinal cord and traumatic brain injury.J. Neurotrauma37517527. 10.1089/neu.2018.5959

  • 73

    NeumannM.WangY.KimS.HongS. M.JengL.BilgenM.et al (2009). Assessing gait impairment following experimental traumatic brain injury in mice.J. Neurosci. Methods1763444. 10.1016/j.jneumeth.2008.08.026

  • 74

    NiX.-J.WangX.-D.ZhaoY.-H.SunH.-L.HuY.-M.YaoJ.et al (2017). The effect of low-intensity ultrasound on brain-derived neurotropic factor expression in a rat sciatic nerve crushed injury model.Ultrasound Med. Biol.43461468. 10.1016/j.ultrasmedbio.2016.09.017

  • 75

    Niewiadomska-CimickaA.DoussauF.PerotJ. B.RouxM. J.KeimeC.HacheA.et al (2021). SCA7 mouse cerebellar pathology reveals preferential downregulation of key Purkinje cell-identity genes and shared disease signature with SCA1 and SCA2.J. Neurosci.4149104936. 10.1523/JNEUROSCI.1882-20.2021

  • 76

    NoristaniH. N.TheyL.PerrinF. E. (2018). C57BL/6 and swiss webster mice display differences in mobility, gliosis, microcavity formation and lesion volume after severe spinal cord injury.Front. Cell. Neurosci.12:173. 10.3389/fncel.2018.00173

  • 77

    OkuwaY.ToriumiT.NakayamaH.ItoT.OtakeK.KuritaK.et al (2018). Transplantation effects of dental pulp-derived cells on peripheral nerve regeneration in crushed sciatic nerve injury.J. Oral Sci.60526535. 10.2334/josnusd.17-0462

  • 78

    O’LearyT. P.GunnR. K.BrownR. E. (2013). What are we measuring when we test strain differences in anxiety in mice?.Behav. Genet.433450. 10.1007/s10519-012-9572-8

  • 79

    PachecoJ. M.Hines-LanhamA.StrattonC.MehosC. J.McCurdyK. E.PinkowskiN. J.et al (2019). Spreading depolarizations occur in mild traumatic brain injuries and are associated with postinjury behavior.Eneuro6ENEURO.007019.2019. 10.1523/ENEURO.0070-19.2019

  • 80

    PerezH.AbdallahM. F.ChaviraJ. I.NorrisA. S.EgelandM. T.VoK. L.et al (2021). A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.Elife10:e64695. 10.7554/eLife.64695

  • 81

    PinkowskiN. J.GuerinJ.ZhangH.CarpentierS. T.McCurdyK. E.PachecoJ. M.et al (2020). Repeated mild traumatic brain injuries impair visual discrimination learning in adolescent mice.Neurobiol. Learn. Mem.175:107315. 10.1016/j.nlm.2020.107315

  • 82

    PöttkerB.StöberF.HummelR.AngensteinF.RadyushkinK.GoldschmidtJ.et al (2017). Traumatic brain injury causes long-term behavioral changes related to region-specific increases of cerebral blood flow.Brain Struct. Funct.22240054021. 10.1007/s00429-017-1452-9

  • 83

    QinL.JingD.ParaudaS.CarmelJ.RatanR. R.LeeF. S.et al (2014). An adaptive role for BDNF Val66Met polymorphism in motor recovery in chronic stroke.J. Neurosci.3424932502.

  • 84

    RadlickaA.JabłońskaJ.LenarczykM.SzumiecŁHardaZ.BagińskaM.et al (2023). Nonmotor symptoms associated with progressive loss of dopaminergic neurons in a mouse model of Parkinson’s disease.bioRxiv [Preprint]. 10.1101/2023.01.23.525182

  • 85

    RitzelR.LiY.LeiZ.CarterJ.ChoiH.KhanN.et al (2021). Age-related dysregulation of autophagy contributes to microglial dysfunction and chronic neurobehavioral deficits after traumatic brain injury.Res. Squ. [Preprint]. 10.21203/rs.3.rs-1021695/v1

  • 86

    RitzelR. M.LiY.HeJ.KhanN.DoranS. J.FadenA. I.et al (2020). Sustained neuronal and microglial alterations are associated with diverse neurobehavioral dysfunction long after experimental brain injury.Neurobiol. Dis.136:104713. 10.1016/j.nbd.2019.104713

  • 87

    RoccaC. J.GoodmanS. M.DulinJ. N.HaquangJ. H.GertsmanI.BlondelleJ.et al (2017). Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich’s ataxia.Sci. Transl. Med.9:eaaj2347. 10.1126/scitranslmed.aaj2347

  • 88

    RotermundC.TruckenmüllerF. M.SchellH.KahleP. J. (2014). Diet-induced obesity accelerates the onset of terminal phenotypes in α-synuclein transgenic mice.J. Neurochem.131848858. 10.1111/jnc.12813

  • 89

    RothF.FernandesM.ValenteS.SantosJ.FurukawaR.FernandesC.et al (2017). Platelet-rich fibrin conduits as an alternative to nerve autografts for peripheral nerve repair.J. Reconstruct. Microsurg.33549556. 10.1055/s-0037-1603355

  • 90

    SaalK. A.KochJ. C.TatenhorstL.SzegoÉM.RibasV. T.MichelU.et al (2015). AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson’s disease in vitro and in vivo.Neurobiol. Dis.73150162. 10.1016/j.nbd.2014.09.013

  • 91

    SchönfeldL.-M.JahanshahiA.LemmensE.SchipperS.DooleyD.JoostenE.et al (2017). Long-term motor deficits after controlled cortical impact in rats can be detected by fine motor skill tests but not by automated gait analysis.J. Neurotrauma34505516. 10.1089/neu.2016.4440

  • 92

    SchweizerR.SchniderJ. T.FanzioP. M.TsujiW.KosterevaN.SolariM. G.et al (2020). Effect of systemic adipose-derived stem cell therapy on functional nerve regeneration in a rodent model.Plast. Reconstr. Surg. Glob. Open8:e2953. 10.1097/GOX.0000000000002953

  • 93

    SowaA. S.MartinE.MartinsI. M.SchmidtJ.DeppingR.WeberJ. J.et al (2018). Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.Proc. Natl. Acad. Sci. U. S. A.115E2624E2633. 10.1073/pnas.1716071115

  • 94

    StreijgerF.BeerninkT. M. J.LeeJ. H. T.BhatnagarT.ParkS.KwonB. K.et al (2013). Characterization of a cervical spinal cord hemicontusion injury in mice using the infinite horizon impactor.J. Neurotrauma30869883. 10.1089/neu.2012.2405

  • 95

    SuH.-L.ChiangC.-Y.LuZ.-H.ChengF.-C.ChenC.-J.SheuM.-L.et al (2018). Late administration of high-frequency electrical stimulation increases nerve regeneration without aggravating neuropathic pain in a nerve crush injury.BMC Neurosci.19:37. 10.1186/s12868-018-0437-9

  • 96

    TatenhorstL.EckermannK.DambeckV.Fonseca-OrnelasL.WalleH.LopesT.et al (2016). Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease.Acta Neuropathol. Commun.4:39. 10.1186/s40478-016-0310-y

  • 97

    Thau-ZuchmanO.GomesR. N.DyallS. C.DaviesM.PriestleyJ. V.GroenendijkM.et al (2019). Brain phospholipid precursors administered post-injury reduce tissue damage and improve neurological outcome in experimental traumatic brain injury.J. Neurotrauma362542. 10.1089/neu.2017.5579

  • 98

    TimotiusI. K.BielerL.Couillard-DespresS.SandnerB.Garcia-OvejeroD.LabombardaF.et al (2021). Combination of defined catwalk gait parameters for predictive locomotion recovery in experimental spinal cord injury rat models.ENeuro8ENEURO.049720.2021. 10.1523/ENEURO.0497-20.2021

  • 99

    TimotiusI. K.CannevaF.MinakakiG.MoceriS.CasadeiN.RiessO.et al (2018a). “Systematic data analysis and data mining in gait analysis by heat mapping,” in 11th international conference on methods and techniques in behavioral research (Measuring behavior 2018) (Manchester: MMU). 4349. Available online at: https://archive.measuringbehavior.org/mb2018/Publications.html

  • 100

    TimotiusI. K.CannevaF.MinakakiG.PasluostaC.MoceriS.CasadeiN.et al (2018b). Dynamic footprint based locomotion sway assessment in α-synucleinopathic mice using Fast Fourier Transform and low pass filter.J. Neurosci. Methods296111. 10.1016/j.jneumeth.2017.12.004

  • 101

    TimotiusI. K.CannevaF.MinakakiG.MoceriS.PlankA.-C.CasadeiN.et al (2019). Systematic data analysis and data mining in CatWalk gait analysis by heat mapping exemplified in rodent models for neurodegenerative diseases.J. Neurosci. Methods326:108367. 10.1016/j.jneumeth.2019.108367

  • 102

    TruongK.AhmadI.Jason ClarkJ.SelineA.BertrocheT.MostaertB.et al (2018). Nf2 mutation in schwann cells delays functional neural recovery following injury.Neuroscience374205213. 10.1016/j.neuroscience.2018.01.054

  • 103

    TsikaE.KannanM.FooC. S. Y.DikemanD.GlauserL.GellhaarS.et al (2014). Conditional expression of Parkinson’s disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration.Neurobiol. Dis.71345358. 10.1016/j.nbd.2014.08.027

  • 104

    VandeputteC.TaymansJ.-M.CasteelsC.CounF.NiY.van LaereK.et al (2010). Automated quantitative gait analysis in animal models of movement disorders.BMC Neurosci.11:92. 10.1186/1471-2202-11-92

  • 105

    VidalP. M.KaradimasS. K.UlndreajA.LaliberteA. M.TetreaultL.FornerS.et al (2017). Delayed decompression exacerbates ischemia-reperfusion injury in cervical compressive myelopathy.JCI Insight2:e92512. 10.1172/jci.insight.92512

  • 106

    WahlstenD.MettenP.PhillipsT. J.BoehmS. L.Burkhart-KaschS.DorowJ.et al (2003). Different data from different labs: Lessons from studies of gene-environment interaction.J. Neurobiol.54283311. 10.1002/neu.10173

  • 107

    WalterJ.KovalenkoO.YounsiA.GrutzaM.UnterbergA.ZweckbergerK. (2020). The CatWalk XT® is a valid tool for objective assessment of motor function in the acute phase after controlled cortical impact in mice.Behav. Brain Res.392:112680. 10.1016/J.BBR.2020.112680

  • 108

    WangX. H.LuG.HuX.TsangK. S.KwongW. H.WuF. X.et al (2012). Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease.BMC Neurosci.13:142. 10.1186/1471-2202-13-142

  • 109

    WangY.LiuX.HuT.LiX.ChenY.XiaoG.et al (2021). Astragalus saponins improves stroke by promoting the proliferation of neural stem cells through phosphorylation of Akt.J. Ethnopharmacol.277:114224. 10.1016/j.jep.2021.114224

  • 110

    WeberJ. J.HaasE.MaringerY.HauserS.CasadeiN. L. P.ChishtiA. H.et al (2020). Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph disease.Hum. Mol. Genet.29892906. 10.1093/hmg/ddaa010

  • 111

    WertheimL.EdriR.GoldshmitY.KaganT.NoorN.RubanA.et al (2022). Regenerating the injured spinal cord at the chronic phase by engineered iPSCs-derived 3D neuronal networks.Adv. Sci.2105694111. 10.1002/advs.202105694

  • 112

    WilkeC.HaasE.ReetzK.FaberJ.Garcia-MorenoH.SantanaM. M.et al (2020). Neurofilaments in spinocerebellar ataxia type 3: Blood biomarkers at the preataxic and ataxic stage in humans and mice.EMBO Mol. Med.12:e11803. 10.15252/emmm.201911803

  • 113

    XuY.TianN. X.BaiQ. Y.ChenQ.SunX. H.WangY. (2019). Gait assessment of pain and analgesics: Comparison of the DigiGait and CatWalk™ Gait Imaging systems.Neurosci. Bull.35401418. 10.1007/s12264-018-00331-y

  • 114

    ZampognaA.MiletiI.PalermoE.CellettiC.PaoloniM.ManoniA.et al (2020). Fifteen years of wireless sensors for balance assessment in neurological disorders.Sensors20:3247. 10.3390/s20113247

  • 115

    ZhengG.ZhangH.TailM.WangH.WalterJ.SkutellaT.et al (2023). Assessment of hindlimb motor recovery after severe thoracic spinal cord injury in rats: Classification of CatWalk XT® gait analysis parameters.Neural Regener. Res.18:1084. 10.4103/1673-5374.355763

  • 116

    ZhengZ. Y.LuG.XiongZ. Q.LeungC. K.SuX. W.LiT.et al (2021). Integrated analysis of gait parameters and gene expression profiles in a murine model of subarachnoid hemorrhage.Genes Brain Behav.20:e12728. 10.1111/gbb.12728

  • 117

    ZhuF.FanM.XuZ.CaiY.ChenY.YuS.et al (2018). Neuroprotective effect of rapamycin against Parkinson’s disease in mice.J. Zhejiang Univ. Med. Sci.47465472.

Summary

Keywords

CatWalk XT, gait, rodents, mouse, CNS, PNS, locomotor deficits

Citation

Timotius IK, Roelofs RF, Richmond-Hacham B, Noldus LPJJ, von Hörsten S and Bikovski L (2023) CatWalk XT gait parameters: a review of reported parameters in pre-clinical studies of multiple central nervous system and peripheral nervous system disease models. Front. Behav. Neurosci. 17:1147784. doi: 10.3389/fnbeh.2023.1147784

Received

19 January 2023

Accepted

16 May 2023

Published

07 June 2023

Volume

17 - 2023

Edited by

Nuno Sousa, University of Minho, Portugal

Reviewed by

Emmanuel Moyse, Université de Tours, France; Patrick Noël Pallier, Queen Mary University of London, United Kingdom

Updates

Copyright

*Correspondence: Lior Bikovski,

ORCID: Bar Richmond-Hacham, orcid.org/0000-0003-0698-9764

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics